Sterling Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$271K Buy
2,087
+2,068
+10,884% +$235K 0.01% 1021
2026
Q2
$1.89K Sell
19
-15
-44% -$1.51K ﹤0.01% 3003
2026
Q1
$3.01K Sell
34
-2
-6% -$172 ﹤0.01% 2893
2025
Q4
$2.83K Buy
36
+23
+177% +$1.75K ﹤0.01% 3019
2025
Q3
$871 Hold
13
– – ﹤0.01% 3102
2025
Q2
$1.22K Sell
13
-48
-79% -$5.27K ﹤0.01% 3029
2025
Q1
$7.24K Sell
61
-51
-46% -$6.95K ﹤0.01% 1984
2024
Q4
$14.8K Buy
112
+99
+762% +$12.2K ﹤0.01% 1984
2024
Q3
$1.69K Buy
+13
New +$1.53K ﹤0.01% 2261

Other funds holding MLAB

Sterling Capital Management's MLAB Position: Q3 2026 in Review

Sterling Capital Management increased its Mesa Laboratories (MLAB) stake by 10,884% in Q3 2026, buying an estimated $235K and bringing the position to 2,087 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #1021.

Sterling Capital Management first reported a position in MLAB in Q3 2024 and has held it in 9 quarters since. 27 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Sterling Capital Management held 2,087 shares of Mesa Laboratories worth $271K as of Q3 2026.
  • Sterling Capital Management bought 2,068 Mesa Laboratories shares in Q3 2026, an estimated $235K.
  • Mesa Laboratories made up 0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1021 holding.
  • Sterling Capital Management first reported a position in Mesa Laboratories in Q3 2024 and has held it in 9 quarters since.
  • 27 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.